We’re Making Moves To Serve You Better
YMC America just completed the combination and expansion of our US operations at our YMC campus in Devens, MA.
This puts our columns and stationary phase team under the same roof (actually, several roofs) with the research, design, and manufacturing teams of our large-scale purification systems.
What does this mean for you?
Our bigger facility means more inventory, better service, and expanded resources. The new facility complies with ISO 9001:2015 guidelines.
We are also expanding our laboratory services to include more testing, training, and support, with new labs in Devens and Thousand Oaks, CA.
Read the complete announcement about our recent moves here.
Previous Article
YMC Scale Up Platform Product Array Related Posts
June 2, 2026
Chromatography of Biotherapeuticals – Analyzing and Purifying Peptides and Oligonucleotides
This webinar will highlight how advanced ultra-high-performance liquid chromatography (UHPLC) strategies, carefully selected stationary phases, and bioinert hardware can significantly improve the analysis and purification of peptides and oligonucleotides.
May 21, 2026
Breaking Down mRNA Capping Efficiency with High-Resolution IP-RP LC
Evaluating 5' capping efficiency is a critical quality attribute in therapeutic mRNA manufacturing, directly impacting translation efficiency and transcript stability. However, separating structurally similar capped, partially capped, and uncapped species differing by just a single nucleotide remains a significant chromatographic challenge.
May 7, 2026
Revolutionizing CRISPR Applications: High-Resolution sgRNA Analysis
Ensuring the quality of single guide RNA (sgRNA) is a major hurdle in CRISPR-Cas genome editing. Because these molecules are large (~100mer) and prone to complex secondary structures, separating them from nearly identical impurities requires precision. Our latest application note
